| | Alternative Medicine | Magnetic Therapy

Electroconvulsive Therapy (ECT): Modern Practice, Safety & Indications

ECT has not stopped—it remains a gold-standard treatment for severe, treatment-resistant psychiatric conditions. Modern ECT bears little resemblance to historical depictions: it is administered under brief general anesthesia with muscle paralysis, using ultra-brief pulse, right-unilateral electrode placement to maximize efficacy and minimize cognitive side effects.

Current Indications (APA / NICE Guidelines)

Major depressive disorder (MDD) with psychotic features, catatonia, high suicidality, or failure of ≥2 adequate antidepressant trials
Bipolar depression or mania unresponsive to medications
Schizophrenia with catatonia or treatment-resistant positive symptoms
Neuroleptic malignant syndrome
Severe autism-related self-injury (selected cases)

Treatment Course

Acute series: 2–3 sessions/week × 6–12 treatments (individualized)
Continuation/maintenance ECT: weekly → biweekly → monthly to prevent relapse
Each session: 5–10 min procedure; 30–60 min total with recovery

Safety Profile

Informed Consent Essentials

Explanation of risks/benefits/alternatives (including ketamine, TMS, MAOIs)
Capacity assessment (may involve surrogate if impaired)
Documentation of voluntary consent per state law

Access & Stigma

ECT is available at most academic medical centers and many community hospitals. Stigma persists despite robust evidence; advocacy by NAMI, APA, and patient groups continues to improve access.

Magnetic Therapy - Related Articles

Aspect	Modern ECT
Mortality	~1 in 50,000 treatments (comparable to minor surgery)
Anesthesia	Methohexital or propofol + succinylcholine/rocuronium
Monitoring	EEG, ECG, BP, SpO₂, ETCO₂, EMG
Common side effects	Headache, myalgia, nausea (day of); anterograde/retrograde memory gaps (weeks)
Cognitive mitigation	Right-unilateral ultra-brief pulse; seizure threshold titration; interictal interval optimization